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INTRODUCTION
Motin et al.1 were the first to report the forma-
tion of a fibrin sheath around a catheter inserted into
the subclavian vein. They termed the sheath “fibrin
sleeve,” without assessing its components. Since that
time, a fibrin sleeve has been considered a common
reaction between blood and catheter.2–4 A catheter
sleeve (CS) could be formed as early as 24 hours
after catheterization.2 The reported incidence of a
“fibrin sleeve” ranges from 42% to 100%, and its
reported length is variable.5–7 The sleeve itself usu-
ally does not cause clinical symptoms,8 but has been
regarded as the cause of several catheter-related
problems. Withdrawal occlusion is the condition in
which the catheter remains functional for infusion,
but aspiration of blood is no longer feasible. It is
thought that temporary occlusion of the catheter tip
is caused by the flap valve effect of the “fibrin
sleeve.”9 Some authors consider a CS to be a cause
of pulmonary embolism, especially after removal of
the catheter.5,10,11 The sleeve could also act as a
nidus for bacterial colonization.11
The “fibrin sleeve” has received much less atten-
tion than 2 other catheter-related complications,
mural thrombosis and catheter lumen clotting.
Moreover, the reaction between catheter and vein
wall has not been studied. What happens to the
sleeve after withdrawal of the catheter is not known.
As part of a continuing study of long-term central
venous catheterization in an animal model, the for-
mation of a catheter-sleeve, its composition, its rela-
tion with the vein wall, and its fate after withdrawal
of the catheter was examined.
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Purpose: After catheterization, 42% to 100% of central venous catheters are surrounded
by a “fibrin sleeve.” This sleeve has been considered the cause of catheter-related infec-
tions, withdrawal occlusion, and pulmonary embolism. The reactions between the vein
wall and the catheter were studied.
Methods: A silicone catheter was placed in the anterior caval vein of 123 rats. After in situ
fixation at scheduled intervals, the pathologic changes were studied on semi-serial histo-
logic sections by means of light microscopy, transmission electron microscopy, and scan-
ning electron microscopy (SEM). In 36 rats, the catheter was withdrawn immediately; in
72 rats, it was left in situ up to 6 months; and in 15 rats, the study was performed up to
10 months after withdrawal of a catheter that had remained in situ for 6 months.
Results: In the group in which the catheter was withdrawn immediately, mural thrombi
disappeared by day 7. In the group in which the catheter remained in situ, thrombi
remained around the proximal portion of the catheter. This pericatheter thrombosis
(PCT) was invaded by migrating and proliferating smooth muscle cells (SMCs), origi-
nating from an injured vein wall, and transformed from day 7 into a tissue composed
predominantly of SMCs and collagen and covered by endothelial cells. Later, the num-
ber of cells decreased, and the relative amount of collagen increased. Up to 10 months
after withdrawal of the catheter, the collapsed sleeve was still present within the vein.
Conclusion: The sleeve around a central venous catheter is not a fibrin sleeve, but a sta-
ble cellular-collagen tissue covered by endothelium. It is mainly formed by smooth mus-
cle cells migrating from the injured vein wall into the early pericatheter thrombus. 
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MATERIAL AND METHODS
Catheters
The catheters used in this study were Dow
Corning Silastic Medical Grade Tubing, with internal
and external diameters of 0.51 mm and 0.94 mm. This
diameter resulted in a catheter to vein ratio of about
0.7 (jugular vein) and about 0.25 (vena cava), which is
roughly comparable with introducing a Hickman
catheter 12.5F via the external jugular vein in humans.
Animals and groups
All animals received proper care in compliance
with the “Guide for the Care and Use of Laboratory
Animals” formulated by the National Academy of
Sciences and published by the National Institutes of
Health (NIH publication number 85-23, revised
1985), and in compliance with the guidelines of the
local ethical committee of the Catholic University of
Leuven.
One hundred twenty-three male Wistar rats (initial
weight, 250 g) were used. The animals were obtained
from the Laboratory Animals Centre K.U. Leuven and
were bred under minimal disease conditions. They
were kept under a 12-hour-light–12-hour–dark sched-
ule at an ambient temperature of 23°C and fed stan-
dard rat chow and tap water ad libitum.
Three main experimental groups were made:
1. Immediate withdrawal group (n = 36): The
catheter was immediately withdrawn after being
inserted into the vein twice. The rats were killed
after 1 day, 3 days, 7 days, 2 weeks, 2 months, or
4 months (6 in each group).
2. Catheter in situ group (n = 72): Fifty-four rats
were divided into 9 subgroups (6 in each group).
They were killed after a catheterization period of 1
day, 3 days, 7 days, 14 days, 21 days, 1 month, 2
months, 4 months, or 6 months. Eighteen rats
used for SEM were divided into 6 groups (3 in
each group). They were killed after 3 days, 6 days,
9 days, 14 days, 2 months, or 6 months. The peri-
ods were selected according to the results from a
pilot study.
3. Postcatheterization group (n = 15): In 9 rats, the
catheter was withdrawn after a 2-month catheter-
ization period. The rats were kept another 2
weeks (n = 3) or 2 months (n = 6) before being
killed. In 6 rats, the catheterization period was 6
months, and they were killed 10 months after
catheter withdrawal. 
Surgical procedure
All surgical procedures were performed under
aseptic conditions. The rats were anaesthetized using
an intramuscular injection of 2.4 ml/kg body weight
of a mixture of 2 ml Fentanyl and 2 ml Dehydro-
benzperidol (fentanylum, 0.05 mg/ml and droperi-
dol, 5 mg/2 ml). The left posterior facial vein (PFV)
and left jugular vein (LJV) were gently exposed
through a mid-line incision on the ventral side of the
neck. A venous cutdown was made in the left PFV,
and a Silastic catheter was inserted into the anterior
vena cava (AVC). The length of the implanted
catheter was 4 cm. This corresponded to the distance
between the beginning of the jugular vein and the
end of the AVC, as determined in a pilot study. The
left PFV was ligated around the catheter; the end
emerging from the vein was closed after a bolus injec-
tion of Heparin solution (100 IU/ml) and embed-
ded subcutaneously. The wound was closed.
Throughout the procedure, care was taken to avoid
unnecessary manipulation of the vein. The catheter
was left in the vein for the scheduled time. In the
immediate withdrawal group, the catheter was with-
drawn after being inserted twice into the vein. In the
“postcatheterization group,” the catheter was with-
drawn after 2 months in some rats and 6 months in
others, and the vein was ligated.
Fixation and Dissection
The same anaesthetic protocol described above
was used. The original incision was opened, and the
LJV, RJV, and left carotid artery (LCA) were exposed.
Two centimeter–long catheters were inserted into the
LCA and the RJV. After heparinization (1000
IU/kg), an intravenous bolus of anaesthetics was
given in the RJV to kill the animals. A 10% buffered
formalin solution (pH = 7.4) was infused for 5 min at
a physiologic pressure of 100 mm Hg in the LCA
(inflow), and the RJV was used as outflow. To avoid
collapse of the lumen, the veins that were to be sub-
jected to light microscopy (LM) and transmission elec-
tron microscopy (TEM) were infused with a gelatin
barium suspension (0.05 g/100 ml, heated to 35°C)
from the RJV. After cooling of the animal for 1 hour
at room temperature, the left facial vein (LFV), JV,
AVC (including the catheter), and the heart were
excised in one block, with the surrounding tissue, and
immersed in formalin overnight before further pro-
cessing. The tissue specimens were serially cut into 8
blocks, 0.5 cm in length and numbered consecutively
from the beginning of the LJV (number 1) to the end
of the AVC (number 8). Segment 1 (S1) through seg-
ment 4 (S4) represented the external JV from the
union of the PFV and anterior facial veins (AFV) to
the junction with the axillary vein. Segment 5 (S5) to
segment 8 (S8) represented the AVC. S3 was further
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divided in 2 parts (0.25 cm each); the cranial part was
prepared for TEM examination, and the caudal part
was prepared for LM examination. The cranial part of
S3 was also inspected by means of LM, with 1 m m sec-
tions stained with toluidine blue that were prepared
for TEM. The veins submitted to SEM and the veins
from the postcatheterization group were fixated and
dissected using the same method, except the filling
suspension was omitted, and they were opened longi-
tudinally. After macroscopical examination, the veins
were cut in 8 segments (each 0.5 cm).
Histochemistry and immunohistochemistry.
Fixed tissue was processed for histological examina-
tion in a standard way to study the time course of
formation and the composition of the sleeve.
Initially, all tissue slides were stained with hema-
toxylin and eosin. Masson’s trichrome stain was used
to recognize collagen, and Mallory’s phospho-
tungstic acid-hematoxylin (PTAH) stain was used to
demonstrate fibrin. Van Gieson’s elastic stain was
used to further delineate the elastic laminas.
For immunohistochemical staining, the strepta-
vidin-biotin peroxidase method was used. Incubation
with smooth muscle cell-specific anti a -actin anti-
bodies (Dako M851 1/40) identified the presence of
smooth muscle cells in the sleeve. Incubation with
anti-von Willebrand factor (factor VIII) (Dako A082
1/100) was used to identify endothelial cells.
A total of 840 segments was examined by light
microscopy, and representative photographs were
made.
TEM. Tissue blocks of 1 mm were fixed in 2.5%
glutaraldehyde in 0.1 M sodium phosphate buffer
(pH = 7.2) at 4°C for 2 hours. After rinsing in 0.1
M sodium phosphate buffer for 6 · 5 min, they were
post-fixed in 1% osmium tetroxide in 0.1 M sodium
phosphate buffer (pH = 7.2) for 1 hour and then
dehydrated and embedded in Dow epoxy resin.
Sections of 1 m m stained with toluidine blue were
examined with a light microscope. Areas of interest
were trimmed of superfluous tissue, and 50 nm sec-
tions were cut, mounted on copper grids, stained
with uranyl acetate and lead citrate, and examined
with a Philips CM10 electron microscope at 60 kV.
Thirty-nine segments were examined.
Scanning electron microscopy. The tissue seg-
ments for SEM were post-fixed in 1% osmium tetrox-
ide. They were dehydrated through a graded alcohol
series, critical-point dried with CO2, and sputter-
coated with gold palladium. Then they were exam-
ined using a Philips XL 40 scanning electron micro-
scope at 10 kV. Fifty-four segments were scanned.
RESULTS
Immediate withdrawal group 
Denudation of endothelium, but no signs of
SMC injury, could be seen. At day 1, thrombi were
present in S1 (100%), S2 (83%), and S3 (17%). At
day 3, less thrombus was found in S1 (50%), S2
(17%), and S3 (0%). From day 7, thrombi could no
longer be found, and the vein wall was re-endothe-
lialized. On later sections, no vein wall change could
be identified. 
Catheter in situ group 
Early vein wall injury. After 3 days of catheter-
ization, denudation of endothelial cells (ECs), focal
hemorrhage, and round cell infiltration could be
observed in the vein wall next to the catheter mold
by means of LM. Different degrees of injury could
be observed in this area. Disruption of the EC mem-
brane, disappearance of ECs with exposure of the
sub-endothelial layer and of smooth muscle cells
(SMCs) was seen by means of SEM.
Cellular oedema, cystically dilated rough endo-
plasmic reticulum, cell lysis with pyknotic nuclei,
and dispersion of organelles were shown with TEM
(Fig. 1). Some of the SMCs next to the catheter
were modulating their phenotype from the contrac-
tile one to the synthetic one, characterized by a
large amount of rough endoplasmic reticulum,
Golgi apparatus, free ribosomes, and sparse filament
bundles.
Pericatheter thrombus (1-3 days). Pericatheter
thrombosis was present in all 12 rats after 1 day and 3
days of catheterization, but only in segments S1
(100%), S2 (75%), S3 (50%), and S4 (25%). The 
distribution at day 3 was not different from that at 
day 1.
Day 1
A mesh-like tissue, called pericatheter thrombus
(PCT), was found between the catheter mold and
the denuded vein wall in S1 through S4. It was
formed by aggregation of platelets and fibrin, inter-
spersed with areas of red blood cells and scattered
leukocytes packed within a fibrin mesh. This mesh
was positive for fibrin on PTAH and negative for
collagen on Masson’s trichrome staining. No a -actin
positive cells could be observed in this PCT (Fig. 2,
A, B, C).
Day 3
On LM, the thrombi had the same histological
appearance, but were thicker and protruded more
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towards the lumen of the vessel. In the interface
between vein wall and thrombus, very few a -actin
positive cells infiltrated into the PCT. These cells
were confirmed by means of TEM to be SMCs of
the synthetic phenotype.
Transformation of pericatheter thrombus to a
cellular-collagen sleeve (1–4 weeks). After about 7
days, the composition of the tissue surrounding the
catheter was very different compared with the initial
PCT. Two phases could be observed: a predomi-
nantly cellular phase initially, followed by a mixed cel-
lular-extracellular matrix phase from day 14 on.
Around 1 week
The PCT was infiltrated by numerous cells stain-
ing for a -actin (Fig. 3, A, B, C). Their orientation
was uniform from the area adherent to the vein wall
down into the catheter sleeve (CS). More a -actin
positive cells were found in the zone near the vein
wall than in the zone near the catheter (Fig. 4). They
were also found in the bridges connecting the vein
wall with the CS (Fig. 5). By means of TEM, these
cells were found to be of the synthetic phenotype
(Fig. 6; Fig. 7, A, B).
Only a small amount of extracellular matrix
(ECM) was present in this predominantly cellular
tissue. Collagen, characterized by positive Masson’s
trichrome staining on LM and by fibril periodicity of
64 nm and a diameter of about 10–12 nm on TEM,
was the main component. Masson’s trichrome stain-
ing was more intense near the vein wall. On PTAH
staining, a limited amount of fibrin was visible in the
area near the catheter where no a -actin positive cells
were found. Many microvessels could be seen in the
bridges connecting vein wall and sleeve.
On day 6, the surface of CS was partially covered
by endothelial cells with bulging nuclei on SEM. In
the uncovered areas, a mesh structure was still visible.
On day 9, the sleeve surface was almost completely
covered by a typical cobblestone pattern of cuboid
endothelial cells, oriented in the direction of the
blood flow (Fig. 8). On LM, these cells stained pos-
itive for anti-factor VIII. On TEM, they appeared to
be activated endothelial cells, showing numerous
endocytotic vesicles, an euchromatic nucleus, and a
prominent nucleolus.
Week 2
The sleeve was a mixture of SMCs and collagen.
The amount of SMCs and ECM increased as more
collagen fibrils were produced by SMCs of synthetic
phenotype. Occasionally elastin, characterized by a
matrix surrounded by filaments, could be found in
the extracellular space. Clefts covered by ECs and
containing red blood cells were visible in the CS and
resembled vasa vasorum. The CS was covered by a
complete layer of less-bulging endothelial cells.
These cells were supported by a continuous base-
ment membrane and attached to each other by tight
junctions and gap junctions on TEM.
Weeks 3 to 4
A continuous spectrum of SMC phenotypes,
ranging from synthetic via intermediate to con-
tractile, was found in the vein wall next to the
catheter mold, in the bridges, and in the sleeve
itself by means of TEM. The volume of collagen
increased, and it became organized in thicker,
Fig. 1. Day 3: Some smooth muscle cells in the vein wall
close to the catheter show signs of injury: membrane dis-
ruption (solid triangle), cytoplasmic debris and autophago-
cytotic bodies (arrow), pycnotic nuclei (open
triangle)(TEM 12600· ).
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Fig. 2. A, Day 1: A pericatheter thrombus (PCT) is present between the vein wall (V) and the
catheter mold (C) (original magnification, 25· ; HE stain). B, The pericatheter thrombus is
negative on Masson’s trichrome stain (original magnification, 25· ; Trichrome stain). C, In the
vein wall (V), a thin continuous layer of a -actin positive cells represents the muscle layer. No
a -actin stain can be observed in the pericatheter thrombus (PCT) (original magnification, 25· ;
a -actin stain). 
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Fig. 3. A, Day 7: The former pericatheter thrombus is populated by numerous cells and can
be called a catheter sleeve (CS) (V = vein wall; C = catheter) (original magnification, 25· ; HE
stain). B, Masson’s trichrome stain in the sleeve (CS) is more intense near the vein wall (V)
than near the catheter mold (C). In some areas negative on Masson’s trichrome stain, almost
no a -actin stain is visible (arrow)(original magnification, 400· ; Trichrome stain). C, a -actin
positive cells are more intense in the zone of the sleeve near the vein wall (arrow) than in the
zone near the catheter mold (star) (original magnification, 25· ; a -actin stain). 
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coiled bundles. There was more elastin, but it was
not organized as a layer.
The later appearance of the catheter sleeve
(2–6 months). The number of cells and
microvessels decreased, and the relative volume of
collagen increased progressively with time.
Collagen was the major component of the sleeve at
4 months and 6 months. Only 2 or 3 layers of
sparsely distributed a -actin positive cells and a few
microvessels were seen in the sleeve and in the
bridge. 
On TEM, all SMCs were of the contractile pheno-
type. The covering ECs had the morphology of quies-
cent endothelial cells, when examined by means of
TEM. On SEM, EC covering was observed in all rep-
resentative segments along the length of the sleeve.
A summary of the catheter sleeve formation is
presented in Table I.
Fig. 5. Day 7: Several connecting bridges (B) divide the barium-filled space (star) between
the vein wall (V) and the catheter sleeve (CS). These tiny bridges, filled with a -actin positive
cells, indicate the migratory pathway of the smooth muscle cells (original magnification, 200· ;
a -actin stain). 
Fig. 4. Day 7: The a -actin positive cells are distributed in a stream-like pattern from the vein
wall (V) along the adherent areas (star) into the catheter sleeve (CS). Cell density is higher in
the vicinity of the vessel wall and decreases towards the catheter mold (C) (original magnifica-
tion 100· ; a -actin stain) 
FPO
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Localization of the sleeve. A sleeve was found
in all 42 rats after 1 week to 6 months of catheteri-
zation. In 35 rats, the sleeve consisted of only 1 por-
tion, constantly originating from the entrance point
at the vein and extending into the JV, and sometimes
into the AVC. In the other 7 rats (17%), a second
separate portion of sleeve was present in the AVC,
but its composition was identical. The sleeve was
incorporated with the vein wall or linked to the vein
wall by bridges on all slides on which it was present. 
The distribution of the sleeve in the different
venous segments and at different intervals is pre-
sented in Table II. 
Postcatheterization group
The fate of the sleeve after withdrawal of the
catheter. On macroscopical examination, a semi-
translucent residual sleeve was clearly visible in the
vein of all rats 2 weeks, 2 months, and 10 months
after catheter withdrawal. This remnant was mainly
found in the jugular vein, adherent to the vein wall,
and contained some clots in its lumen. The distribu-
Fig. 6. Day 7: This overview picture of the sleeve shows
a layer of endothelial cells (EC) at the luminal side, sever-
al layers of smooth muscle cells of the synthetic phenotype
(star) with collagen (0) in between, and still some fibrin
(F) at the catheter side(TEM, 1440· ).
Fig. 7. A, Day 7: A smooth muscle cell (arrow) migrates
from the vein wall (V) into the bridge (B) to the catheter
sleeve (CS). (TEM, 2610· ). B, Higher magnification of
the cell indicated in A shows its synthetic phenotype: large
amounts of rough endoplasmatic reticulum, free ribo-
somes, and only a few filament bundles. The pseudopodia
(triangle) are the hallmark of migration (TEM, 12600· ).
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tion curve of sleeve and sleeve remnant is presented
in Fig. 9.
On microscopical examination, the sleeve could
be identified as a collapsed tube connected to the
vein wall by bridges. There were clots in its lumen,
and it was covered by endothelial cells. Its wall con-
tained collagen and a -actin positive cells, but no fib-
rin (Fig. 10). 
DISCUSSION
Since 1964, it has become widely accepted that a
sleeve composed of fibrin is formed around a central
Fig. 8. Day 14: The SEM image taken after 14 days of
catheterization shows that the bridges (B) between the
vein wall (V) and the catheter sleeve (CS) and the surface
of the sleeve are covered by nicely oriented endothelial
cells (arrow)(SEM, 300· ).
Fig. 9. The distribution curve of catheter sleeve (CS) and
sleeve remnant (SR).
Table I. Overview of sleeve formation
Interval Pathological process Proposed terms
Day 1–3 A thrombus is formed between the injured vein wall and the catheter. SMCs Pericatheter thrombus
in injured vein wall modulate their phenotype from contractile to synthetic.
Weeks 1–2 Pericatheter thrombus transforms to a tissue: catheter sleeve, composed mainly 
of synthetic phenotype SMCs and collagen, covered by endothelial cells.
Weeks 3–4 Synthetic phenotype SMCs are reverting to a contractile phenotype. A spectrum Catheter sleeve
of phenotypes of SMCs is present.
Month 2 The number of SMCs decreases, and the relative volume of collagen increases. 
SMCs are only of the contractile phenotype.
Months 4–6 Collagen is the major component of the sleeve.
10 months after The sleeve is still present as a collapsed structure adherent to the vein wall. Sleeve remnant
catheter withdrawal
SMCs, smooth muscle cells.
Table II. The distribution of catheter sleeve in the different venous segments after 1 week to 6 months of
catheterization
Time S1 S2 S3 S4 S5 S6 S7 S8
7 days 6/6 6/6 5/6 2/6 0/6 1/6 0/6 0/6
14 days 6/6 6/6 6/6 2/6 1/6 0/6 0/6 0/6
21 days 6/6 6/6 4/6 1/6 0/6 0/6 0/6 0/6
1 month 6/6 6/6 5/6 3/6 1/6 1/6 0/6 0/6
2 months 6/6 6/6 4/6 3/6 2/6 1/6 0/6 0/6
4 months 6/6 6/6 4/6 3/6 1/6 2/6 0/6 0/6
6 months 6/6 6/6 6/6 3/6 2/6 1/6 1/6 1/6
Total number 42/42 42/42 34/42 17/42 7/42 6/42 1/42 1/42
% 100 100 80.9 40.5 16.7 14.3 2.4 2.4
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venous catheter.1–4,7,11 The sleeve is considered a
predictable consequence of exposing an artificial sur-
face to blood.8 Only a few papers deal with its micro-
scopic structure, and its evolution over time is never
discussed. Hoshal et al.2 first described the
histopathology of a sleeve as “adherent to a vein wall,
showing fibrin deposition with no evidence of
endothelialization or organization.” This concept
was supported by other short-term studies.3,4,7,11
However, O’Farrell et al.12 reported that the sheath
was not composed of fibrin, but progressed from a
thrombus into fibrous connective tissue. In this
study, only light microscopy, Masson’s trichrome,
and PTAH stains were used. Methodology and tim-
ing were inappropriate in determining the type of
cells present in the sleeve and their origin.
The short- and long-term observations made in
our morphological study allow us to formulate a new
concept about the formation of the catheter sleeve.
The contact between vein wall and catheter results in
denudation of endothelial cells and activation of
SMCs. The occurring thrombus is gradually trans-
formed into a cellular-collagen tissue by migrating
and proliferating SMCs.
A PCT is an early event after catheterization 
and is formed where the catheter damages the
vein wall
PCT was found in segments S1, S2, S3, and S4,
but did not cover the whole length of the catheter.
This result suggests that a permanent thrombus
around the catheter is not a predictable consequence
of blood exposure to a silicone surface; other factors
must intervene.
It is known that a foreign body in the blood
stream activates the coagulation system at its surface
and becomes coated by protein. Plasma proteins such
as fibrinogen and fibrin will be deposited on the
catheter surface. This is followed by adhesion and
aggregation of platelets producing the basic building
blocks of a thrombus, namely platelet-fibrin aggre-
gates that activate the intrinsic coagulation system.
Cellular elements such as red blood cells and leuko-
cytes will get entrapped.13 At the same time, the fib-
rinolytic system will participate, and the ultimate
result will depend on the final equilibrium between
thrombogenic and thrombolytic mechanisms.14
Our results prove that both introducing the
catheter and having it in situ cause damage to the
vein wall and thrombosis, but with a very different
evolution. After introduction and immediate with-
drawal of the catheter, the thrombus disappears
quickly. When the catheter is left in situ, the throm-
bus remains in areas where the catheter is in contact
with the vein wall. The catheter is a constant source
of injury because of its pressure against the vein
wall10 and the rubbing caused by respiratory, car-
diac,15,16 and body movements.17,18
Permanent catheterization could also cause local
stasis. Several animal studies demonstrated that with-
out stasis thrombi will be cleared away by throm-
bolytic activity within a few days.14,19 Sigel19 empha-
sized that prolonged presence of thrombi after elec-
Fig. 10. Ten months after withdrawal of the catheter, the remnant of the collapsed sleeve (R)
is easily recognized by the clot (triangle) in its center, and the bridges (star) linking it with the
vein wall (V) (original magnification, 100· ; toluidine blue stain).
FPO
trical injury was observed only in combination with
stasis. Both endothelial damage and local stasis are
important factors in permanent thrombosis after
catheterization. This factor also explains why the
localization of PCT in our study is in S1 through S4,
because the diameter of the vein increases consider-
ably from S5 on.
Catheter-induced vein wall injury leads to activa-
tion of smooth muscle cells
Although the extent of damage to the vein wall
by catheterization was not the subject of this study,
we did observe clear evidence of reversible and irre-
versible injury to SMCs near the catheter mold, and
of modulation of SMCs from contractile to synthetic
phenotype. As described in the studies on vessel
injury, which were mostly done in arteries with bal-
loon catheter injury, several growth factors are
released by the injured ECs, SMCs, or both.20,21
These growth factors stimulate the cells via an
autocrine pathway and neighboring cells via a
paracrine pathway.22,23 After stimulation, SMCs
modify their phenotype from a contractile to a syn-
thetic one that renders them susceptible to prolifera-
tion and migration.24,25
Migration of SMCs from the injured vein wall
into the PCT is an important step for its trans-
formation to a cellular-collagen tissue
O’Farrell12 recently reported that the sleeve is
composed of fibroblasts and collagen after 2 months
of catheterization. However, the use of a -actin stain
and TEM allowed us to prove that the cells in the
sleeve are SMCs. The selected intervals made it clear
that these cells were originally located in the vein
wall. No SMC was observed in the PCT at day 1, but
SMCs were present at the interface between vein wall
and PCT at day 3 and densely populated the PCT at
day 7. Therefore SMC migration is an important
step. The stream-like distribution of SMCs from vein
wall to sleeve and the bridges linking sleeve and vein
wall that were observed in 150 slides underscore this
observation. In a preliminary study using PCNA and
a -actin double staining, proliferating SMCs were
present in the vein wall, bridges, and thrombi. SMCs
were shown to be the predominant cells of the cellu-
lar component by means of TEM. We observed only
few neutrophils infiltrating the pericatheter throm-
bus and assume that these cells do not play an impor-
tant role in the formation of the catheter sleeve.
Schwartz et al.26 also observed that neutrophils are
not a prerequisite for the proliferative response, par-
ticularly in the rat.
EC regeneration 
The time course of endothelialization of the sur-
face of the catheter sleeve is comparable with what
has been described in arteries27,28 and veins29 after
injury. However, balloon injury of carotid artery
often results in areas that remain permanently de-
endothelialized. In rabbits, the cessation of growth
occurred 3 mm from the edge of the denuded area
after 2 weeks, and in rats, the cessation of growth
occurred 10 mm from the edge of the denuded area
after 6 weeks.30
Re-endothelialization occurred more rapidly in
aortic injury because endothelial cells could migrate
from uninjured branches.25 Our data suggest that the
whole length of the CS, varying from about 1 cm to
3 cm, could be endothelialized. There is no contra-
diction between this observation and the data men-
tioned above, because the CS only formed where the
catheter was in contact with the vein wall. 
Sleeve remnant
The finding of a remnant of sleeve even 10
months after catheter withdrawal indicates that the
sleeve remains in the vein as a permanent scar. This
confirms the main finding of our work: the sleeve is
composed of a well-organized tissue that cannot be
dissolved in the blood stream. This remnant of sleeve
may not occupy much space in the AVC, but occu-
pies more space in smaller veins. The remnant of
sleeve is permanently attached to the vein wall, mak-
ing it a very unlikely cause of embolism, as some have
suggested. Benya4 reported an exceptional case of
sleeve eversion during catheter withdrawal. This is in
keeping with the strength of the sleeve as expected
from its composition, which does not break into
pieces as easily as fibrin.
Localization of the sleeve
The incidence of sleeve formation obviously
decreased from S1 to S8. This suggests a correlation
with the diameter of the vein, which is known to
increase from the jugular vein to the vena cava.
However, in 17% of the rats a separate, second por-
tion of sleeve was found in S5 through S8. Because
on all slides on which the sleeve was present the
sleeve was always found to be in contact with the vein
wall, we suggest that contact is an important factor.
The smaller the ratio between vein and catheter
diameter, the more contact one might expect.
Catheter sleeve and mural thrombosis
Williams8 summarized the state of knowledge
about catheter-related thrombosis in 1990: fibrin
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sleeve around the catheter and mural thrombosis on
the vein wall. We did find thrombosis on the vein
wall in S1 through S4, but after one week it trans-
formed to a cellular-collagen sleeve. In S5 through
S8, we found a sleeve in some rats and mural throm-
bi in other rats, but never both on the same slide
(data not shown). These findings raise several ques-
tions that need further study.
SUMMARY
The tissue around the catheter is a thrombus in
the early stage, but a cellular-collagen tissue covered
by endothelium after 1 week. Migration and prolifer-
ation of activated SMCs from the vein wall to the
PCT is an important step in its transformation. 
Motin introduced the term “fibrin sleeve” to
describe a visible sheath around the catheter seen at
autopsy. Although fibrin coating occurs, the visible
sleeve is not composed of fibrin. Therefore it is
appropriate to distinguish fibrin coating and catheter
sleeve.
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